A review of the cost-effectiveness of interventions to prevent sexual transmission of HIV in the United States

AIDS and Behavior

Volumn 6, Issue 1, 2002, Pages 15-31

  Pinkerton, Steven D ^a,b   Johnson Masotti, Ana P ^a   Holtgrave, David R ^b   Farnham, Paul G ^b,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Cost effectiveness; Economic analysis; Human immunodeficiency virus; Prevention

Indexed keywords

ADOLESCENCE; ADOLESCENT; ADULT; ARTICLE; CONDOM; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH ECONOMICS; HETEROSEXUALITY; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; QUALITY ADJUSTED LIFE YEAR; SEXUAL TRANSMISSION; UNITED STATES; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0036522650     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014572427706     Document Type: Article

References (91)

1. Allard, R. (1990a). A family of mathematical models to describe the risk of infection by a sexually transmitted agent. Epidemiology, 1, 30-33.
2. Allard, R. (1990b). A mathematical model to describe the risk of infection from sharing injection equipment. Journal of Acquired Immune Deficiency Syndromes, 3, 1010-1016.
3. Bedimo, A. L., Pinkerton, S. D., Cohen, D. A., Gray, B., and Farley, T. A. (in press). Cost-savings of a condom social marketing program. International Journal of STD and AIDS.
4. Brandeau, M. L., Owens, D. K., Sox, C. H., and Wachter, R. M. (1993). Screening women of childbearing age for human immunodeficiency virus: A model-based policy analysis. Management Science, 39, 72-92.
5. Brown, B. S., and Beschner, G. M. (Eds.). (1993). Handbook of Risk of AIDS: Injection Drug Users and Sexual Partners. Westport, CT: Greenwood.
6. Centers for Disease Control. (1995). Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994. Morbidity and Mortality Weekly Report, 44, 929-933.
7. Centers for Disease Control and Prevention. (1999). HIV/AIDS Surveillance Report, 11, 1-44.
8. Choi, K. H., and Coates, T. J. (1994). Prevention of HIV infection. AIDS, 8, 1371-1389.
9. Cohen, D. A., Farley, T. A., Bedimo-Etame, J. R., Scribner, R., Ward, W., Kendall, C., and Rice, J. (1999). Implementation of a condom social marketing program in Louisiana, 1993 to 1996. American Journal of Public Health, 89, 204-208.
10. Coyle, S. L., Needle, R. H., and Normand, J. (1998). Outreach-based HIV prevention for injecting drug users: A review of published outcome data. Public Health Reports, 113(Suppl. 1), 19-30.
11. Drummond, M. F., O'Brien, B., Stoddart, G. L., and Torrance, G. W. (1997). Methods for the Economic Evaluation of Health Care Programmes (2nd Ed.). New York: Oxford University Press.
12. Fabian, R. (1994). The QUALY approach. In G. Tolley, D. Kenkel, and R. Fabian (Eds.), Valuing Health for Policy: An Economic Approach (pp. 118-136). Chicago: University of Chicago Press.
13. Farnham, P. G. (1998). Economic evaluation of HIV counseling and testing programs. The influence of program goals on evaluation. In D. R. Holtgrave (Ed.), Handbook of Economic Evaluation of HIV Prevention Programs (pp. 63-79). New York: Plenum.
14. Farnham, P. G., Pinkerton, S. D., Holtgrave, D. R., and Johnson-Masotti, A. P. (2002). Cost-effectiveness of counseling and testing to prevent sexual transmission of HIV in the United States. AIDS and Behavior, 6, 33-43.
15. Ganiats, T. G., and Wong, A. F. (1991). Evaluation of cost-effectiveness research: A survey of recent publications. Family Medicine, 23, 457-462.
16. Gold, M. R., Siegel, J. E., Russell, L. B., and Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
17. Gorsky, R. D., Haddix, A. C., and Shaffer, P. A. (1996). Cost of an intervention. In A. C. Haddix, S. M. Teutsch, P. A. Shaffer, and D. O. Duñet (Eds.), Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation (pp. 57-75). New York: Oxford University Press.
18. Guinan, M. E., Farnham, P. G., and Holtgrave, D. R. (1994). Estimating the value of preventing a human immunodeficiency virus infection. American Journal of Preventive Medicine, 10, 1-4.
19. Haddix, A. C., Teutsch, S. M., Shaffer, P. A., and Duñet, D. O. (Eds.). (1996). Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York: Oxford University Press.
20. Higgins, D. L., Galavotti, C., O'Reilly, K. R., Schnell, D. J., Moore, M., Rugg, D. L., and Johnson, R. (1991). Evidence for the effects of HIV antibody counseling and testing on risk behaviors. Journal of the American Medical Association, 266, 2419-2429.
21. Holtgrave, D. R. (1994a). Cost analysis and HIV prevention programs. American Psychologist, 49, 1088-1089.
22. Holtgrave, D. R. (1994b). Setting priorities and community planning for HIV-prevention programs. AIDS & Public Policy Journal, 9, 145-151.
23. Holtgrave, D. R. (1998). The cost-effectiveness of the components of a comprehensive HIV prevention program. In D. R. Holtgrave (Ed.), Handbook of economic evaluation of HIV prevention programs (pp. 127-134). New York: Plenum.
24. Holtgrave, D. R., and Kelly, J. A. (1996). Preventing HIV/AIDS among high-risk urban women: The cost-effectiveness of a behavioral group intervention. American Journal of Public Health, 86, 1442-1445.
25. Holtgrave, D. R., and Kelly, J. A. (1997). Cost-effectiveness of an HIV/AIDS prevention intervention for gay men. AIDS and Behavior, 1, 173-180.
26. Holtgrave, D. R., and Pinkerton, S. D. (1997). Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16, 54-62.
27. Holtgrave, D. R., and Pinkerton, S. D. (1998). The cost-effectiveness of small group and community-level interventions. In D. R. Holtgrave (Ed.), Handbook of Economic Evaluation of HIV Prevention Programs (pp. 120-127). New York: Plenum.
28. Holtgrave, D. R., and Pinkerton, S. D. (2001). Implications of economic evaluations for national HIV prevention policy makers. In E. H. Kaplan and R. Brookmeyer (Eds.), Quantitative evaluation of HIV prevention programs (pp. 32-54). New York: Oxford University Press.
29. Holtgrave, D. R., and Qualls, N. L. (1995). Threshold analysis and programs for prevention of HIV infection. Medical Decision Making, 15, 311-317.
30. Holtgrave, D. R., Qualls, N. L., Curran, J. W., Valdiserri, R. O., Guinan, M. E., and Parra, W. C. (1995). An overview of the effectiveness and efficiency of HIV prevention programs. Public Health Reports, 110, 134-146.
31. Holtgrave, D. R., Qualls, N. L., and Graham, J. D. (1996). Economic evaluation of HIV prevention programs. Annual Review of Public Health, 17, 467-488.
32. Hughes, D., and Morris, S. (1996). The cost-effectiveness of condoms in the prevention of HIV infection in England and Wales: Should condoms be available on prescription? Journal of Health Services Research and Policy, 1, 205-211.
33. Ickovics, J., Morrill, A., Beren, S., Walsh, U., and Rodin, J. (1994). Limited effects of HIV counseling and testing for women. Journal of the American Medical Association, 272, 443-448.
34. Institute of Medicine Committee on HIV Prevention Strategies in the United States. (2000). No Time to Lose - Getting More from HIV Prevention. Washington, DC: National Academy Press.
35. Jemmott, J. B. III, Jemmott, L. S., and Fong, G. T. (1992). Reductions in HIV risk-associated sexual behaviors among black male adolescents: Effects of an AIDS prevention intervention. American Journal of Public Health, 82, 372-377.
36. Johnson-Masotti, A. P., Pinkerton, S. D., and Holtgrave, D. R. (2000a). Prioritization methods for HIV prevention community planning. Journal of Public Health Management and Practice, 6, 72-85.
37. Johnson-Masotti, A. P., Pinkerton, S. D., Kelly, J. A., and Stevenson, L. Y. (2000b). Cost-effectiveness of an HIV risk reduction intervention for adults with severe mental illness. AIDS Care, 12, 321-332.
38. Kahn, J. G. (1996). The cost-effectiveness of HIV prevention targeting: How much more bang for the buck? American Journal of Public Health, 86, 1709-1712.
39. Kahn, J. G., and Haynes-Sanstad, K. C. (1997). The role of cost-effectiveness analysis in assessing HIV-prevention interventions. AIDS and Public Policy Journal, 12, 21-30.
40. Kahn, J. G., Washington, A. E., Showstack, J. A., Berlin, M., Phillips, K., and Watson, S. (1992). Updated estimates of the impact and cost of HIV prevention in injection drug users (Report prepared for the Centers for Disease Control). San Francisco: Institute for Health Policy Studies, University of California.
41. Kaplan, E. H. (1989a). What are the risks of risky sex? Modeling the AIDS epidemic. Operations Research, 37, 198-209.
42. Kaplan, E. H. (1989b). Needles that kill: Modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Reviews of Infectious Diseases, 11, 289-298.
43. Kaplan, R. M., and Bush, J. W. (1982). Health-related quality of life measurement for evaluation research and policy analysis. Health Psychology, 1, 61-80.
44. Katz, M. H., and Gerberding, J. L. (1997). Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. New England Journal of Medicine, 336, 1097-1100.
45. Katz, M. H., and Gerberding, J. L. (1998a). Guidelines for Postexposure Prophylaxis (PEP) after Sexual and Drug Exposures to HIV. San Francisco: San Francisco Department of Health/San Francisco General Hospital.
46. Katz, M. H., and Gerberding, J. L. (1998b). The care of persons with recent sexual exposure to HIV. Annals of Internal Medicine, 128, 306-312.
47. Kelly, J. A., McAuliffe, T. L., Sikkema, K. J., Murphy, D. A., Somlai, A. M., Mulry, G., Miller, J. G., Stevenson, L. Y., and Fernandez, M. I. (1997). Reduction in risk behavior among adults with severe mental illness who learn to advocate for HIV prevention. Psychiatric Services, 48, 1283-12188.
48. Kelly, J. A., Murphy, D. A., Sikkema, K. J., and Kalichman, S. C. (1993). Psychological interventions to prevent HIV infection are urgently needed: New priorities for behavioral research in the second decade of AIDS. American Psychologist, 48, 1023-1034.
49. Kelly, J. A., Murphy, D. A., Washington, C. D., Wilson, T. S., Koob, J. J., Davis, D. R., Ledezma, G., and Davantes, B. (1994). The effect of HIV/AIDS intervention groups for high-risk women in urban clinics. American Journal of Public Health, 84. 1918-1922.
50. Kelly, J. A., St. Lawrence, J. S., Diaz, Y. E., Stevenson, L. Y., Hauth, A. C., Brasfield, T. L., Kalichman, S. C., Smith, J. E., and Andrew, M. E. (1991). HIV risk behavior reduction following intervention with key opinion leaders of population: An experimental analysis. American Journal of Public Health, 81, 168-171.
51. Kelly, J. A., St. Lawrence, J. S., Hood, H. V., and Brasfield, T. L. (1989). Behavioral intervention to reduce AIDS risk activities. Journal of Consulting and Clinical Psychology, 57, 60-67.
52. Lurie, P., Miller, S., Hecht, F., Chesney, M., and Lo, B. (1998). Postexposure prophylaxis after nonoccupational HIV exposure. Journal of the American Medical Association, 280, 1769-1773.
53. National Institutes of Health. (1997). Consensus Development Conference Statement on Interventions to Prevent HIV Risk Behavior. Bethesda, MD: NIH Office on Medical Applications of Research.
54. NIMH Multisite HIV Prevention Trial. (1997a). Methodological overview of a multisite HIV prevention trial for populations at risk for HIV. AIDS, 11(Suppl. 2), S1-S11.
55. NIMH Multisite HIV Prevention Trial. (1997b). Conceptual basis and procedures for the intervention in a multisite HIV prevention trial. AIDS, 11(Suppl. 2), S29-S35.
56. NIMH Multisite HIV Prevention Trial Group. (1998). The NIMH Multisite HIV Prevention Trial: Reducing HIV sexual risk behavior. Science, 280, 1889-1894.
57. Norton, E. C., Martin, R. F., and Wechsberg, W. M. (1998). Threshold analysis of AIDS outreach and intervention. In D. R. Holtgrave (Ed.), Handbook of Economic Evaluation of HIV Prevention Programs (pp. 195-209). New York: Plenum.
58. Otto-Salaj, L. L., Kelly, J. A., Stevenson, L. Y., Hoffmann, R., and Kalichman, S. C. (2000). Outcomes of a randomized small-group HIV prevention intervention trial for people with serious mental illness. Community Mental Health Journal, 37, 123-144.
59. Owens, D. K. (1998). Interpretation of cost-effectiveness analyses. Journal of General Internal Medicine, 13, 716-717.
60. Paltiel, A. D., and Stinnett, A. A. (1998). Resource allocation and the funding of HIV prevention. D. R. Holtgrave (Ed.), Handbook of Economic Evaluation of HIV Prevention Programs (pp. 135-152). New York: Plenum.
61. Patrick, D. L., and Erikson, P. (1993). Health Status and Health Policy: Allocating Resources to Health Care. New York: Oxford University Press.
62. Peterson, J. L., and DiClemente, R. J. (2000). Handbook of HIV Prevention. New York: Kluwer Academic.
63. Pinkerton, S. D., and Abramson, P. R. (1998). The Bernoulli-process model of HIV transmission: Applications and implications. In D. R. Holtgrave (Ed.), Handbook of Economic Evaluation of HIV Prevention Programs (pp. 13-32). New York: Plenum.
64. Pinkerton, S. D., Abramson, P. R., and Holtgrave, D. R. (1999). What is a condom worth? AIDS and Behavior, 3, 301-312.
65. Pinkerton, S. D., and Holtgrave, D. R. (1998a). A method for evaluating the economic efficiency of HIV behavioral risk reduction interventions. AIDS and Behavior, 2, 189-201.
66. Pinkerton, S. D., and Holtgrave, D. R. (1998b). Assessing the cost-effectiveness of HIV prevention interventions. In D. R. Holtgrave (Ed.), Handbook of Economic Evaluation of HIV Prevention Programs (pp. 34-44). New York: Plenum.
67. Pinkerton, S. D., and Holtgrave, D. R. (2000). How HIV treatment advances affect the cost-effectiveness of prevention. Medical Decision Making, 20, 89-94.
68. Pinkerton, S. D., Holtgrave, D. R., and Bloom, F. R. (1997b). Postexposure treatment of HIV. New England Journal of Medicine, 337, 500-501.
69. Pinkerton, S. D., Holtgrave, D. R., and Bloom, F. R. (1998e). Cost-effectiveness of postexposure prophylaxis following sexual exposure to HIV. AIDS, 12, 1067-1078.
70. Pinkerton, S. D., Holtgrave, D. R., DiFranceisco, W., Semaan, S., Coyle, S. L., and Johnson-Masotti, A. P. (2000a). Cost-threshold analyses of the National AIDS Demonstration Research HIV prevention interventions. AIDS, 14, 1257-1268.
71. Pinkerton, S. D., Holtgrave, D. R., DiFranceisco, W. J., Stevenson, L. Y., and Kelly, J. A. (1998c). Cost-effectiveness of a community-level HIV risk reduction intervention. American Journal of Public Health, 88, 1239-1242.
72. Pinkerton, S. D., Holtgrave, D. R., DiFranceisco, W. J., Stevenson, L. Y., and Kelly, J. A. (1998d). Cost-effectiveness of a community-level HIV prevention intervention research trial. In D. R. Holtgrave (Ed.), Handbook of Economic Evaluation of HIV Prevention Programs (pp. 243-260). New York: Plenum.
73. Pinkerton, S. D., Holtgrave, D. R., and Jemmott, J. B. (2000b). Economic analysis of an HIV risk reduction intervention for male African American adolescents. Journal of Acquired Immune Deficiency Syndromes, 25, 164-172.
74. Pinkerton, S. D., Holtgrave, D. R., Johnson-Masotti, A. P., Turk, M. E., Hackl, K. L., DiFranceisco, W., and the NIMH Multi-site HIV Prevention Trial Group. (2002). Cost-effectiveness of the NIMH Multisite HIV Prevention Intervention. AIDS and Behavior, 6, 83-96.
75. Pinkerton, S. D., Holtgrave, D. R., Leviton, L. C., Wagstaff, D. A., and Abramson, P. R. (1998b). Model-based evaluation of HIV prevention interventions. Evaluation Review, 22, 155-174.
76. Pinkerton, S. D., Holtgrave, D. R., and Valdiserri, R. O. (1997a). Cost-effectiveness of HIV-prevention skills training for men who have sex with men. AIDS, 11, 347-357.
77. Pinkerton, S. D., Holtgrave, D. R., Willingham, M., and Goldstein, E. (1998a). Cost-effectiveness analysis and HIV prevention community planning. AIDS and Public Policy Journal, 13, 115-127.
78. Pinkerton, S. D., Johnson-Masotti, A. P., Otto-Salaj, L. L., Stevenson, L. Y., and Hoffmann, R. G. (2001b). Cost-effectiveness of an HIV risk reduction intervention for mentally ill adults. Mental Health Services Research, 3, 45-55.
79. Pinkerton, S. D., Johnson-Masotti, A. P., Holtgrave, D. R., and Farnham, P. G. (2001a). Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV. AIDS, 15, 917-928.
80. Pinkerton, S. D., Kahn, J. G., and Holtgrave, D. R. (in press). Cost-effectiveness of community-level approaches to HIV prevention: A review. Journal of Primary Prevention.
81. Rehle, T. M., Saidel, T. J., Hassig, S. E., Bouey, P. D., Gaillard, E. M., and Sokal, D. C. (1998). AVERT: A user-friendly model to estimate the impact of HIV/sexually transmitted disease prevention programs on HIV transmission. AIDS, 12(Suppl. 2), S27-S35.
82. Remafedi, G. (1994). Cognitive and behavioral adaptation to HIV/AIDS among gay and bisexual adolescents. Journal of Adolescent Health, 15, 142-148.
83. Schrappe, M., and Lauterbach, K. (1998). Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries. AIDS, 12(Suppl. A), S231-S238.
84. Shriver, M. (1998). Postexposure prophylaxis: A community member's perspective. In D. O. Ostrow and S. C. Kalichman (Eds.), Psychosocial and Public Health Impacts of new HIV Therapies (pp. 171-182). New York: Plenum.
85. Tao, G., and Remafedi, G. (1998). Economic evaluation of an HIV prevention intervention for gay and bisexual male adolescents. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17, 83-90.
86. Tengs, T. O., Adams, M. E., Pliskin, J. S., Safran, D. G., Siegel, J. E., Weinstein, M. C., and Graham, J. D. (1995). Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis, 15, 369-390.
87. Valdiserri, R. O., Aultman, T. V., and Curaan, J. W. (1995). Community Planning: A national strategy to improve HIV prevention programs. Journal of Community Health, 20, 87-99.
88. Valdiserri, R. O., Lyter, D. W., Leviton, L. C., Callahan, C. M., Kingsley, L. A., and Rinaldo, C. R. (1989). AIDS prevention in homosexual and bisexual men: Results of a randomized trial evaluating two risk reduction interventions. AIDS, 3, 21-26.
89. Weinhardt, L. S., Carey, M. P., Johnson, B. T., and Bickham, N. L. (1999). Effect of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985-1997. American Journal of Public Health, 89, 1397-1405.
90. Weinstein, M. C., Graham, J. D., Siegel, J. E., and Fineberg, H. V. (1989). Cost-effectiveness analysis of AIDS prevention programs: Concepts, complications, and illustrations. In C. F. Turner, H. G. Miller, and L. E. Moses (Eds.), AIDS: Sexual Behavior and Intravenous Drug Use (pp. 471-499). Washington, DC: National Academy Press.
91. Winkler, M. A. (1999). The need for concrete improvement in abstract quality. Journal of the American Medical Association, 281, 1129-1130.